close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

Kodu・Aktsiate loetelu・Virbac SA
Search

Virbac SA

Avatud

SektorTervishoid

349.5 -1.83

Osta

Hinna uuendus 18. nov 2025, 09:41 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

350.5

Max

358

Põhinäitajad

By Trading Economics

Sissetulek

32M

82M

Müük

44M

738M

P/E

Sektori keskmine

21.771

105.69

Dividenditootlus

0.42

Kasumimarginaal

11.162

Töötajad

6,365

EBITDA

41M

157M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+11.06% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.42%

2.37%

Turustatistika

By TradingEconomics

Turukapital

339M

3B

Eelmine avamishind

351.33

Eelmine sulgemishind

349.5

Uudiste sentiment

By Acuity

19%

81%

33 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

303.6 / 306.25 Toetus ja vastupanu

Virbac SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. nov 2025, 18:59 UTC

Suurimad hinnamuutused turgudel

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

DJ

Loe

17. nov 2025, 23:40 UTC

Market Talk

Gold Consolidates Amid Mixed Signals -- Market Talk

DJ

Loe

17. nov 2025, 23:34 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

DJ

Loe

17. nov 2025, 22:58 UTC

Market Talk

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

DJ

Loe

17. nov 2025, 22:46 UTC

Market Talk

Risk Assets Set to Have a Strong 2026 -- Market Talk

DJ

Loe

17. nov 2025, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

DJ

Loe

17. nov 2025, 22:02 UTC

Tulu

Trip.com Group 3Q Rev $2.6B >TCOM

DJ

Loe

17. nov 2025, 22:02 UTC

Tulu

Trip.com Group 3Q Adj EPS $3.87 >TCOM

DJ

Loe

17. nov 2025, 22:02 UTC

Tulu

Trip.com Group 3Q EPS $4.02 >TCOM

DJ

Loe

17. nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

17. nov 2025, 21:40 UTC

Tulu

James Hardie Industries 2Q Adj EPS 26c >JHX

DJ

Loe

17. nov 2025, 21:40 UTC

Tulu

James Hardie Industries 2Q Loss/Shr 10c >JHX

DJ

Loe

17. nov 2025, 21:39 UTC

Tulu

James Hardie Industries 2Q Sales $1.29B >JHX

DJ

Loe

17. nov 2025, 21:38 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

DJ

Loe

17. nov 2025, 21:38 UTC

Tulu

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

DJ

Loe

17. nov 2025, 21:10 UTC

Tulu

XP Inc. 3Q EPS BRL2.47 >XP

DJ

Loe

17. nov 2025, 21:10 UTC

Tulu

XP Inc. 3Q Rev BRL4.67B >XP

DJ

Loe

17. nov 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

DJ

Loe

17. nov 2025, 20:12 UTC

Market Talk

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

DJ

Loe

17. nov 2025, 20:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

17. nov 2025, 20:09 UTC

Market Talk

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

DJ

Loe

17. nov 2025, 19:29 UTC

Market Talk

Gold Slide Continues to Start Week -- Market Talk

DJ

Loe

17. nov 2025, 19:16 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

DJ

Loe

17. nov 2025, 18:20 UTC

Omandamised, ülevõtmised, äriostud

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

DJ

Loe

17. nov 2025, 16:45 UTC

Omandamised, ülevõtmised, äriostud

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

DJ

Loe

17. nov 2025, 16:16 UTC

Tulu
Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

DJ

Loe

17. nov 2025, 16:15 UTC

Tulu

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

DJ

Loe

17. nov 2025, 15:40 UTC

Omandamised, ülevõtmised, äriostud

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

DJ

Loe

17. nov 2025, 15:22 UTC

Omandamised, ülevõtmised, äriostud

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

DJ

Loe

17. nov 2025, 15:19 UTC

Market Talk

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Virbac SA Prognoos

Hinnasiht

By TipRanks

11.06% tõus

12 kuu keskmine prognoos

Keskmine 391.5 EUR  11.06%

Kõrge 415 EUR

Madal 368 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Virbac SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Virbac SA aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

303.6 / 306.25Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Very Strong Bullish Evidence

All events are bullish.

Pikk perspektiiv

Weak Bearish Evidence

Bearish events outweigh bullish events.

Sentiment

By Acuity

33 / 374 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Muud aktsiad sektorist

QDEL

Quidel Corp

21.01

↓-1.5%

NERV

Minerva Neurosciences Inc

4.3

↑ +5.91%

LSTA.US

Lisata Therapeutics

2.02

↓-4.72%
help-icon Live chat